[ DB00087 , a monoclonal antibody against P31358 : hopes and fears ] . P31358 , an antigen expressed on immune cells including mature T lymphocytes , is thought to be involved in immunomodulatory mechanisms . DB00087 is a humanized monoclonal antibody against P31358 , which causes a marked and long-term decrease in immune cells , especially P01730 -positive T lymphocytes . A few randomized clinical trials have revealed the efficacy of alemtuzumab to be much greater than that of interferon-Î² in patients with relapsing-remitting multiple sclerosis . However , the development of other autoimmune disorders , including autoimmune thyroid disorders and thrombocytic purpura , because of alemtuzumab application has been considered an obstacle in its widespread use .